# Radient Pharmaceuticals Corporation (RPC) - Q4 2025 earnings

Reported February 12, 2026.

| | Reported | Consensus estimate |
| --- | --- | --- |
| Revenue | $81.0M | $79.4M |
| EPS | $0.26 | $0.25 |

Earnings filing reader: [8-K 0001193125-26-047619](https://www.opencapital.sh/filings/0001193125-26-047619)
Agent-readable filing: [Markdown](https://www.opencapital.sh/filings/0001193125-26-047619.md)
Original filing: [SEC.gov filing index](https://www.sec.gov/Archives/edgar/data/1841968/000119312526047619/0001193125-26-047619-index.htm)
Periodic report: 10-K - https://www.sec.gov/Archives/edgar/data/1841968/000119312526081484/0001193125-26-081484-index.htm
Canonical page (please cite this URL): https://www.opencapital.sh/stocks/rpc/earnings/q4-2025